Proteomics

Dataset Information

0

NOVEL ROLE OF FATTY ACID SYNTHASE IN ANGIOGENESIS THROUGH MODULATION OF LYSINE MALONYLATION OF MTOR


ABSTRACT: The role of fatty acid synthesis (FAS) in endothelial cells (ECs) remains incompletely characterized. In this project, we found that silencing of fatty acid synthase (FASN) impedes vessel sprouting by reducing EC proliferation. Moreover, loss of FASN in ECs impaired angiogenesis in vivo, and FASN blockade reduced pathological ocular neovascularization. FASN silencing increased malonyl-CoA levels and immunoblotting of EC lysates for malonylated lysine residues (Kmal) revealed that this led to increased levels of protein malonylation. To identify the nature of some of the malonylated proteins we performed a proteomics screen using an anti-Kmal antibody to enrich Kmal peptides from a tryptic digest of EC lysates, and then analyzed Kmal peptides by LC-MS/MS. In proteomics analysis, we identified malonylation of mTOR at lysine 1218, a poorly characterized post-translational modification. Malonylation of mTOR did not compromise the mTORC1 complex stability or lysosomal membrane localization, but reduced the kinase activity of the complex.

INSTRUMENT(S): Q Exactive

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Cell Culture, Endothelial Cell

SUBMITTER: Evy Timmerman  

LAB HEAD: Carmeliet Peter

PROVIDER: PXD006503 | Pride | 2019-07-08

REPOSITORIES: Pride

altmetric image

Publications


The role of fatty acid synthesis in endothelial cells (ECs) remains incompletely characterized. We report that fatty acid synthase knockdown (FASN<sup>KD</sup>) in ECs impedes vessel sprouting by reducing proliferation. Endothelial loss of FASN impaired angiogenesis in vivo, while FASN blockade reduced pathological ocular neovascularization, at >10-fold lower doses than used for anti-cancer treatment. Impaired angiogenesis was not due to energy stress, redox imbalance, or palmitate depletion. Ra  ...[more]

Similar Datasets

2020-05-27 | PXD015809 | Pride
2023-10-24 | PXD035147 | Pride
2024-01-30 | PXD048455 | Pride
2024-01-30 | PXD048526 | Pride
2022-11-17 | PXD038045 | Pride
2022-02-17 | PXD025835 | Pride
2022-05-11 | PXD029366 | Pride
2021-08-19 | PXD027417 | Pride
2023-07-21 | PXD040481 | Pride
2023-03-05 | GSE226139 | GEO